Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
New Highs: Diabetes Stock Breaks Out. Cement Maker Surges Past Buy Point.
02:34pm, Friday, 05'th May 2023
PODD stock hit new highs in March when it joined the S&P 500. Now, shares are breaking out.
Insulet (PODD) Q1 Earnings Beat Estimates, Sales View Up
02:27pm, Friday, 05'th May 2023
Omnipod 5 continues to be a driving force of Insulet's (PODD) strong U.S. growth, representing almost 95% of U.S. new customer starts in the first quarter.
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
07:01pm, Thursday, 04'th May 2023
Insulet (PODD) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.40 per share a year ago.
Buy These 5 Stocks Ahead of Earnings Releases This Week
06:53am, Thursday, 04'th May 2023
We have narrowed our search to five stocks that are set to report earnings results this week. These are: PODD, BKNG, BILL, JCI and COLD.
3 MedTech Stocks Likely to Beat Estimates in Q1 Earnings
09:54am, Wednesday, 26'th Apr 2023
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how BIO, HSIC and PODD are poised ahead of their earnings releases.
Why Insulet (PODD) is Poised to Beat Earnings Estimates Again
01:43pm, Friday, 21'st Apr 2023
Insulet (PODD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Option Trading: Insulet Butterfly Taps Into Stock's Leadership, Potential Rally
10:13am, Friday, 21'st Apr 2023
Health care services and health-related stocks continue to show strength in the market. The post Option Trading: Insulet Butterfly Taps Into Stock's Leadership, Potential Rally appeared first on Inves
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
09:55am, Friday, 21'st Apr 2023
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Insulet Joins S&P 500 And Gets Ready To Pump Up New Breakout With 56% Growth
08:01am, Wednesday, 19'th Apr 2023
After Insulet jumped on news it was joining the S&P 500, PODD stock is wound up for a breakout with earnings due. The post Insulet Joins S&P 500 And Gets Ready To Pump Up New Breakout With 56% Growth
BRKR's Canopy Biosciences Partners With Enable Medicine
09:08am, Thursday, 13'th Apr 2023
BRKR's Canopy Biosciences collaborates with Enable Medicine to bring advanced spatial analysis pipelines to the Canopy CellScape System for high-plex spatial biology.
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
01:14pm, Friday, 07'th Apr 2023
Medical stocks are holding up amid economic and market uncertainty. The post 5 S&P 500 Stocks Showing Strength As Recession Fears Rise appeared first on Investor's Business Daily.
3 Reasons Growth Investors Will Love Insulet (PODD)
02:28pm, Tuesday, 04'th Apr 2023
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Insulet (PODD) Benefits From Omnipod 5 Launch, Expansion
12:58pm, Tuesday, 28'th Mar 2023
Insulet (PODD) witnesses continued uptake of Omnipod through the U.S. pharmacy channel.
Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?
11:29am, Tuesday, 28'th Mar 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Fed Policy Pause & Yellen's Assurance Buoy Wall Street: 5 Picks
10:41am, Friday, 24'th Mar 2023
Thanks to the Fed's willingness to pause its interest rate hikes, it's prudent for investors to place their bets on growth stocks like Comfort Systems USA (FIX), Hershey (HSY), Wynn Resorts (WYNN), In
